Cipher Pharmaceuticals Submits NDA Amendment For CIP-ISOTRETINOIN
Cipher Pharmaceuticals Submits NDA Amendment For CIP-ISOTRETINOIN [Canada Newswire]Published Date: November 23, 2011 07:00:00 AM EST Toronto Stock Exchange Symbol: DNDread more
View ArticlePerrigo Acne Gel Generic Receives FDA Approval
The gel is the generic equivalent of Duac Gel treatment for acne vulgaris. Perrigo Company announced that it has received final approval from the U.S.read more
View ArticleWatson Challenges Epiduo Gel Patent
The company is seeking FDA approval to market a generic version of the topical acne treatment gel. Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an...
View Article
